Published in Cancer Discov on March 11, 2016
Molecular characterization of breast cancer CTCs associated with brain metastasis. Nat Commun (2017) 1.39
The most important questions in cancer research and clinical oncology-Question 2-5. Obesity-related cancers: more questions than answers. Chin J Cancer (2017) 1.33
Liquid biopsies come of age: towards implementation of circulating tumour DNA. Nat Rev Cancer (2017) 0.88
Personalized In Vitro and In Vivo Cancer Models to Guide Precision Medicine. Cancer Discov (2017) 0.87
Meeting report: Metastasis Research Society-Chinese Tumor Metastasis Society joint conference on metastasis. Clin Exp Metastasis (2017) 0.80
Short term ex-vivo expansion of circulating head and neck tumour cells. Oncotarget (2016) 0.80
Enumeration and targeted analysis of KRAS, BRAF and PIK3CA mutations in CTCs captured by a label-free platform: Comparison to ctDNA and tissue in metastatic colorectal cancer. Oncotarget (2016) 0.78
Vesicle-MaNiA: extracellular vesicles in liquid biopsy and cancer. Curr Opin Pharmacol (2016) 0.78
Emerging technologies for salivaomics in cancer detection. J Cell Mol Med (2016) 0.77
Enrichment of circulating head and neck tumour cells using spiral microfluidic technology. Sci Rep (2017) 0.77
The Challenges of Detecting Circulating Tumor Cells in Sarcoma. Front Oncol (2016) 0.77
Implementing liquid biopsies into clinical decision making for cancer immunotherapy. Oncotarget (2017) 0.77
Liquid biopsies for surveillance and monitoring treatment response of bladder cancer. Ann Transl Med (2016) 0.76
Circulating Tumor Cells in the Adenocarcinoma of the Esophagus. Int J Mol Sci (2016) 0.76
Circulating Tumor Cells (CTC) and Cell-Free DNA (cfDNA) Workshop 2016: Scientific Opportunities and Logistics for Cancer Clinical Trial Incorporation. Int J Mol Sci (2016) 0.76
The Cohesive Metastasis Phenotype in Human Prostate Cancer. Biochim Biophys Acta (2016) 0.76
The challenges of tumor genetic diversity. Cancer (2016) 0.76
Liquid biopsy in 2016: Circulating tumour cells and cell-free DNA in gastrointestinal cancer. Nat Rev Gastroenterol Hepatol (2017) 0.75
PD-L1 expressing circulating tumour cells in head and neck cancers. BMC Cancer (2017) 0.75
Blood-Based Analysis of Circulating Cell-Free DNA and Tumor Cells for Early Cancer Detection. PLoS Med (2016) 0.75
Cell-free DNA and next-generation sequencing in the service of personalized medicine for lung cancer. Oncotarget (2016) 0.75
Circulating Tumor Cells: Back to the Future. Front Oncol (2017) 0.75
TP53 mutations on circulating cell-free DNA. EBioMedicine (2016) 0.75
Circulating Tumor Cells in Genitourinary Malignancies: An Evolving Path to Precision Medicine. Front Oncol (2017) 0.75
Tailored Treatment of Colorectal Cancer: Surgical, Molecular, and Genetic Considerations. Clin Med Insights Oncol (2017) 0.75
Detection of Circulating Tumour Cells in Urothelial Cancers and Clinical Correlations: Comparison of Two Methods. Dis Markers (2017) 0.75
Role of circulating free DNA in colorectal cancer. World J Gastrointest Oncol (2016) 0.75
Translating genomic profiling to gastrointestinal cancer treatment. Future Oncol (2017) 0.75
Data-Driven Discovery of Extravasation Pathway in Circulating Tumor Cells. Sci Rep (2017) 0.75
Circulating Cell-Free DNA in Dogs with Mammary Tumors: Short and Long Fragments and Integrity Index. PLoS One (2017) 0.75
Aneuploidy of chromosome 8 in circulating tumor cells correlates with prognosis in patients with advanced gastric cancer. Chin J Cancer Res (2016) 0.75
Tumour microenvironment: informing on minimal residual disease in solid tumours. Nat Rev Clin Oncol (2017) 0.75
Emerging concepts in liquid biopsies. BMC Med (2017) 0.75
Liquid biopsies in bladder cancer-did we find the Holy Grail for biomarker analyses? Transl Androl Urol (2016) 0.75
Recent advances in preoperative management of esophageal adenocarcinoma. F1000Res (2017) 0.75
5-Hydroxymethylcytosine signatures in circulating cell-free DNA as diagnostic biomarkers for human cancers. Cell Res (2017) 0.75
New insights in the clinical and translational relevance of miR483-5p in adrenocortical cancer. Oncotarget (2017) 0.75
Circulating Tumor DNA as Biomarkers for Cancer Detection. Genomics Proteomics Bioinformatics (2017) 0.75
Prognostic Significance of Circulating RET M918T Mutated Tumor DNA in Patients With Advanced Medullary Thyroid Carcinoma. J Clin Endocrinol Metab (2017) 0.75
The Role of BEAMing and Digital PCR for Multiplexed Analysis in Molecular Oncology in the Era of Next-Generation Sequencing. Mol Diagn Ther (2017) 0.75
Biomarkers for early diagnosis, prognosis, prediction, and recurrence monitoring of non-small cell lung cancer. Onco Targets Ther (2017) 0.75